MedMira Inc V.MIR

Alternate Symbol(s): MMIRF

Healthcare Medical Devices

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.

TSXV:MIR - Post by User

MedMira Inc > 5 minute test tackles silent std epidemic

<< Previous

Bullboard Posts

Next >>

Comment by goldyhawkon Jan 09, 2024 1:13pm

99 Views

Post# 35817697

RE:5 minute test tackles silent std epidemic

It seems Medmira started working on the commercialization of Aldretes concept of detecting this sti a year ago
while Medmira is able to get test results rapidly it also is try to help shorten the time required for any treatment from concept to concept to commercialization
i wonder how long it will be to commercialize this TRICH test
Medmira is focused on rapidly commercializing tests for hiv hepatitis c syphilis trich etc etc on single or combined Special MEDMIRA platforms
Medmira is involved in a MIRIAD of endeavours
wonder when they will start making profit

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale